Archives for November 2008

Wisconsin A Leader In Pressure Ulcer Initiatives

The Wisconsin Department of Health Services announces that health care leaders from across the state have formed the Wisconsin Pressure Ulcer Coalition to help reduce pressure ulcers in Wisconsin’s health care industry, including nursing homes and hospitals. A pressure ulcer, also known as a bedsore, is a painful condition that can occur in individuals who [...]

30 November 2008 | Uncategorized | No Comments

ETIPs - Electronic-Targeted Intervention For Psoriasis

Psoriasis affects 2-3% of people in the UK and can create both physical and psychological distress. Psychological discomfort is made worse by the visible nature of the condition whereby some people avoid exposing their [...]

29 November 2008 | Dermatology | No Comments

New Drug For Skin Cancer Approaching Commercialization

A drug that is activated by light can be a quick, simple, and cheap treatment for tens of thousands of patients with skin cancer in Sweden alone. Researcher Leif Eriksson’s team at rebro University in Sweden has now received about SEK 4 million from government research financiers, the Swedish Research Council and Vinnova, to further [...]

28 November 2008 | Dermatology | No Comments

New Biologic Ustekinumab Receives Positive Opinion From European Regulatory Authority For The Treatment Of Moderate To Severe Plaque Psoriasis

Janssen-Cilag announced that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of adults with moderate to severe plaque psoriasis from the European Committee for Medical Products for Human Use (CHMP). People living with psoriasis suffer not only from the symptoms of the disease [...]

28 November 2008 | Uncategorized | No Comments

Enrollment In Provectus’ Phase 2 Melanoma Clinical Trial Reaches Halfway Point

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first fifty percent (40 of 80) of melanoma subjects have been treated in its Phase 2 clinical trial of PV-10. Evaluation of new subjects continues at the trial’s active centers in Adelaide, Brisbane and Sydney, Australia, as well [...]

27 November 2008 | Uncategorized | No Comments

FDA Issues Complete Response Letter For Ceftobiprole For Treatment Of Complicated Skin Infections

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections. The FDA has indicated that [...]

27 November 2008 | Uncategorized | No Comments

Some Asians Taking Certain Epilepsy Medications Might Experience Adverse Skin Reactions, FDA Says

FDA is investigating whether certain medications used to control epileptic seizures can cause severe skin blisters and bleeding for some Asian patients, the AP/Detroit Free Press reports.
Original post by Dermatology News From Medical News Today

26 November 2008 | Dermatology | No Comments

New Biologic Ustekinumab Receives Positive Opinion From European Regulatory Authority For The Treatment Of Moderate To Severe Plaque Psoriasis

Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to severe plaque psoriasis from the European Committee for Medical Products for Human Use (CHMP). This positive opinion takes patients living with the physical and mental burdens of psoriasis a step closer [...]

25 November 2008 | Dermatology | No Comments

Methods For Conducting Magnetic Resonance Angiography Safely In Patients With Contraindications To Gadolinium

Nephrogenic systemic fibrosis (NSF) was first recognized in 1997 and described in 2000, and its association with gadolinium contrast agents was recognized in 2006. NSF is characterized by increased deposits of collagen, most frequently in the skin, but it can be systemic, and in severe cases fatal. There is no [...]

24 November 2008 | Dermatology | No Comments

Does Hard Water Cause Eczema? Kids Aged 6 To 16 Sought To Take Part In A Study - England

Youngsters with eczema are being sought to take part in a study, being supported by specialists at Leicester’s hospitals. The study, which includes consultant dermatologists Dr Robin Graham-Brown and Dr Alex Milligan from Leicester’s hospitals, aims to understand if softer water around the home can improve eczema in children.
Original post [...]

24 November 2008 | Dermatology | No Comments

Navigation

News Archives

Sponsors